CANS - Centre for New Antibacterial Strategies
banner
cansuit.bsky.social
CANS - Centre for New Antibacterial Strategies
@cansuit.bsky.social
CANS is an interdisciplinary centre at UiT The Arctic University of Norway for research, education, innovation and dissemination related to AMR, involving 16 research groups!
https://uit.no/research/cans
Welcome to todays CANS seminar by Professor Thorsten Wohland from the National University of Singapore

Title: Investigation of antimicrobial action on bacteria and biofilms by fluorescence correlation spectroscopy

Where: MH Aud 5
When: 12:00-13:00
October 15, 2025 at 6:35 AM
Reposted by CANS - Centre for New Antibacterial Strategies
What started as a question in a @cansuit.bsky.social seminar ended up in tying an old and clinically valuable phage to a new bacterial threat described at the UiT. Thanks Pauline Cavanagh, Rob Lavigne et al for the collaboration!

virologyj.biomedcentral.com/articles/10....
A link to the past: classical phage ISP infects the recently described Staphylococcus borealis species - Virology Journal
Background Staphylococcal infections, caused by a large variety of species within the Staphylococcus genus, are a threat to human health. Although antibiotics are the current choice of treatment for these infections, bacteriophage (phage) therapy has been used with success against Staphylococcus since the dawn of phage therapy. In 2020 a new coagulase-negative species named Staphylococcus borealis was described in Norway. In this study, we focused on understanding phage infections in S. borealis. Methods: First, we predict the presence of prophages and phage-defence mechanisms in the genomes of a collection of twelve S. borealis strains by bioinformatics. We also attempted to isolate S. borealis-infecting phages from Norwegian samples and tested the host-range of three known staphylococcal phages against a panel of fifty Norwegian staphylococcal strains. Results: The presence of prophages and phage defence systems was verified in all tested S. borealis strains. No local Norwegian phages could be obtained in a phage isolation attempt targeted towards S. borealis. The host range analysis shows that phage ISP, originally isolated in the 1920s and still used for phage therapy to date, can infect S. capitis and the S. borealis Hus23 strain. Phage ISP was shown to limit S. borealis Hus23 growth in liquid cultures and lower the formation of biofilm by the bacterium. The efficiency of plating of phage ISP can be improved by repeated passages in the new S. borealis Hus23 host. Conclusions: here we expand the known host range of the traditional phage ISP by showing that it also infects S. borealis and can be adapted to the new host by serial passages, showcasing the flexibility of phages as an antimicrobial strategy.
virologyj.biomedcentral.com
September 30, 2025 at 6:53 AM
Welcome to todays CANS seminar!

Microbiome-pathogen-host interactions in Clostridioides difficile infection: Nutrients, signals, and future interventions

Presenter: Assistant professor Andrew Hryckowian,
Where: MH Aud 2
When: 14:15-15:00
September 9, 2025 at 7:09 AM
Reposted by CANS - Centre for New Antibacterial Strategies
Welcome to todays CANS seminar presented by Prof. Claus Ernst Moser, University of Copenhagen, Department of Immunology and Microbiology, Bacteriology

Title:
Oral antibiotic treatment of infective endocarditis - the POET study and beyond

Where: MH Aud 5

When: 14:15-15:00
August 25, 2025 at 6:57 AM
🚨 Don’t miss Ahmed Bargeheet’s trial lecture tomorrow & PhD defence on Thu 21st!
📍 uit.no/tavla/artikk...

In connection with the defence, join the microbiome seminar featuring Anne Salonen & Rebecca A. Gladstone 🎤
👉 uit.no/research/can...
Disputas- Master in Applied and Commercial Biotechnology Ahmed Bargheet | UiT
Master in Applied and Commercial Biotechnology Ahmed Bargheet disputerer for ph.d.-graden i helsevitenskap og vil offentlig forsvare avhandlingen:   Dynamics of infant gut resistome and mobilome: Impa...
uit.no
August 19, 2025 at 7:40 AM
Want to hear about Finland's first giant virus?

@gabrielmfa.bsky.social did an excellent interview for a podcast episode in The Naked Scientist 🧪🦠

www.thenakedscientists.com/articles/int...
Finland's first giant virus
Investigative gene-ius...
www.thenakedscientists.com
June 23, 2025 at 8:24 AM
Great to see Lara Ambrosio Leal Dutra representing CANS and presenting her excellent work on bacteriophages during The Danish Viruses of Microbes symposium in Copenhagen! 😀
June 11, 2025 at 1:03 PM
🚼 Findings reveal that newborns given daily probiotics had significantly lower carriage of antibiotic-resistant bacteria.
🌍 Study from rural Tanzania, the #ProRIDe trial shows that we may fight AMR, starting from day one.

🧫 #AMR #Probiotics #GlobalHealth

www.sciencedirect.com/science/arti...
June 3, 2025 at 6:45 AM
Reposted by CANS - Centre for New Antibacterial Strategies
I am proud to have contributed to this groundbreaking work. A heartfelt congratulations to all the authors!
Just published in Lancet Global Health, the Tanzanian-Norwegian ProRIDE controlled trial in 2000 newborn babies found that a 4-week course of probiotics did not reduce death or hospitalization, but reduced gut carriage of multidrug-resistant bacteria in the probiotic group. doi.org/10.1016/s221...
Redirecting
doi.org
June 1, 2025 at 1:00 PM
Welcome to a two part IFA/CANS seminar, presented by Prof. Thomas Rades and Assistant Prof. Hagar Labouta.

Location: Aud 4 MH

10:15-10:50
Title of presentation: Solid Form Diversity of Amorphous Drugs

10:50-11:25
Title of presentation: On-Chip Synthesis and Evaluation of Targeted Nanomedicines
May 15, 2025 at 6:25 AM
Reposted by CANS - Centre for New Antibacterial Strategies
Ferieklar? 😎 Du kan komme til å ta med deg verstingbakterier hjem fra Syden, så husk på de gode gamle smitteverntiltakene som å vaske hendene godt og ofte. Og si fra hvis du har vært innlagt på sykehus i ferien! www.nrk.no/norge/fhi-me...
FHI med nye tall: Stadig flere blir smittet av resistente bakterier
Stadig flere blir smittet av bakterier det nesten ikke finnes medisiner mot. Vi tar bakteriene med oss hjem fra Syden, sier professor.
www.nrk.no
May 7, 2025 at 7:24 AM
New publication alert! 🥳
Jorunn Pauline Cavanagh and colleagues investigated the clinical relevance of the new species Staphylococcus borealis

Have a look 👇
journals.asm.org/doi/10.1128/...
Revealing the clinical relevance of Staphylococcus borealis | Microbiology Spectrum
This study contributes novel knowledge on the clinical relevance of Staphylococcus borealis; this is of importance when clinical microbiologists encounter S. borealis identified in patient samples. S....
journals.asm.org
April 3, 2025 at 9:01 AM
Reposted by CANS - Centre for New Antibacterial Strategies
Thanks for an incredible #CANS-day yesterday! Great discussions and research on #AMR and alternative strategies. Huge thanks to Timothy Walsh and Sílvio Santos for their outstanding keynote lectures! 🎤🔬 #AntimicrobialResistance
March 28, 2025 at 7:42 AM
Reposted by CANS - Centre for New Antibacterial Strategies
It is not everyday that we can name a virus after a city! Long effort finally out now, adding Finland to the giant virus map. On top of this, in-depth structural data. Thanks @lrsundberg.bsky.social @abrescialab.bsky.social et al.

elifesciences.org/articles/103...

@cansuit.bsky.social
Genomic and structural insights into Jyvaskylavirus, the first giant virus isolated from Finland
Jyvaskylavirus, the northernmost isolate of the Marseilleviridae family, shows that giant viruses are also part of the boreal Finnish environment and brings structural information with relevance for u...
elifesciences.org
March 26, 2025 at 7:48 AM
Jeanette Grunnvåg just had an excellent trial lecture! Tune in for her PhD defence today at 11:15

"Targeting virulence: Activity-Based Protein Profiling (ABPP) for Discovery of Potential Therapeutic Targets in Enterococcus faecium"

uit.no/tavla/artikk...
Disputas – Master in Science Jeanette Grunnvåg | UiT
Grunnvåg disputerer for ph.d.-graden i helsevitenskap og vil offentlig forsvare avhandlingen: <br />Targeting virulence: Activity-Based Protein Profiling (ABPP) for Discovery of Potential Therapeutic ...
uit.no
March 14, 2025 at 9:23 AM
Reposted by CANS - Centre for New Antibacterial Strategies
Ladies and gentlemen. All you want to know about Staphylococcus borealis!
pubmed.ncbi.nlm.nih.gov/40071928/
@clauskling.bsky.social
@cansuit.bsky.social

(AI generated illustration)
March 13, 2025 at 3:08 PM
Reposted by CANS - Centre for New Antibacterial Strategies
Hva om du fikk en infeksjon, men vi hadde ikke antibiotika mot den? Vi trenger disse seks grepene for å holde antibiotikaresistensen på avstand:

www.dagensmedisin.no/antibiotika-...
Seks viktige grep i kampen mot antibiotikaresistens
Vi kan lykkes, men det krever modige grep fra helsemyndighetene og private finansieringskilder.
www.dagensmedisin.no
March 12, 2025 at 1:33 PM
Welcome to todays CANS seminar by Kimberly Kline, Univ. of Geneva, Switzerland and Markus Lakemeyer, University of Jena, Germany

'Pathogenesis of Enterococcal biofilm-associated infection'
14:15-15.00

´Chemoproteomic profiling of microbial interactions´
15.00-15.45

MH Aud 5
March 13, 2025 at 8:00 AM
Welcome to todays CANS seminar presented by Professor Abhyudai Singh, University of Delaware

Title: Systems Biology in Single Cells: From Antibiotic Tolerance to Phage Replication

14:15-15:00
MH Aud 2
March 6, 2025 at 12:16 PM
Interested in microbiology and microbiome?

Application is now open for a PhD-position at the research group of Child and Adolescent Health at UiT.

www.jobbnorge.no/en/available...
PhD Candidate in Microbiology (274648) | UiT The Arctic University of Norway
Job title: PhD Candidate in Microbiology (274648), Employer: UiT The Arctic University of Norway, Deadline: Thursday, March 20, 2025
www.jobbnorge.no
February 20, 2025 at 12:48 PM